Cargando…
Leukemia Cancer Mortality Trend in Iran, From 1995 to 2004
BACKGROUND: Cancer is the third most common cause of death in Iran, the leukemia cancer is one of the most important causes of cancer mortality. Regarding cancer mortality, data would be important to monitor the program screening effects, earlier diagnosis, demographic data and other prognostic fact...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Research Center, Shahid Beheshti University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142927/ https://www.ncbi.nlm.nih.gov/pubmed/25250129 |
_version_ | 1782331836380217344 |
---|---|
author | Fazeli, Zeinab Pourhoseingholi, Mohamad Amin Vahedi, Mohsen Abadi, Alireza Fazeli Bavand-Pour, Fatemeh Sadat Baghestani, Ahmad Reza |
author_facet | Fazeli, Zeinab Pourhoseingholi, Mohamad Amin Vahedi, Mohsen Abadi, Alireza Fazeli Bavand-Pour, Fatemeh Sadat Baghestani, Ahmad Reza |
author_sort | Fazeli, Zeinab |
collection | PubMed |
description | BACKGROUND: Cancer is the third most common cause of death in Iran, the leukemia cancer is one of the most important causes of cancer mortality. Regarding cancer mortality, data would be important to monitor the program screening effects, earlier diagnosis, demographic data and other prognostic factors. The aim of this study was mortality rates evaluating, then leukemia cancer trends among the Iranian population within almost a period of a decade, i.e. from 1995 to 2004. METHODS: National death Statistic Reported by Ministry of Health and Medical Education (MOH&ME) from 1995 to 2004, stratified by age group, sex, and cause of death, have included in this study. Leukemia cancer has expressed as the annual mortality rates/100,000, in general, and/or per gender, and age group. RESULTS: The general mortality rate of leukemia cancer has slightly increased within the mentioned study period, from 0.44 to 2.54, then leukemia cancer mortality has often seen in men more than women. CONCLUSION: The mortality rate of leukemia has significantly increased throughout Iran. Associated risk factors with leukemia have headmost identified for their prevention and control. So, future studies to reveal leukemia risk factors among the Iranian population would be crucial in order to control its burden. |
format | Online Article Text |
id | pubmed-4142927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Cancer Research Center, Shahid Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-41429272014-09-23 Leukemia Cancer Mortality Trend in Iran, From 1995 to 2004 Fazeli, Zeinab Pourhoseingholi, Mohamad Amin Vahedi, Mohsen Abadi, Alireza Fazeli Bavand-Pour, Fatemeh Sadat Baghestani, Ahmad Reza Iran J Cancer Prev Original Article BACKGROUND: Cancer is the third most common cause of death in Iran, the leukemia cancer is one of the most important causes of cancer mortality. Regarding cancer mortality, data would be important to monitor the program screening effects, earlier diagnosis, demographic data and other prognostic factors. The aim of this study was mortality rates evaluating, then leukemia cancer trends among the Iranian population within almost a period of a decade, i.e. from 1995 to 2004. METHODS: National death Statistic Reported by Ministry of Health and Medical Education (MOH&ME) from 1995 to 2004, stratified by age group, sex, and cause of death, have included in this study. Leukemia cancer has expressed as the annual mortality rates/100,000, in general, and/or per gender, and age group. RESULTS: The general mortality rate of leukemia cancer has slightly increased within the mentioned study period, from 0.44 to 2.54, then leukemia cancer mortality has often seen in men more than women. CONCLUSION: The mortality rate of leukemia has significantly increased throughout Iran. Associated risk factors with leukemia have headmost identified for their prevention and control. So, future studies to reveal leukemia risk factors among the Iranian population would be crucial in order to control its burden. Cancer Research Center, Shahid Beheshti University of Medical Sciences 2013 /pmc/articles/PMC4142927/ /pubmed/25250129 Text en © 2014 Cancer Research Center, Shahid Beheshti University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Article Fazeli, Zeinab Pourhoseingholi, Mohamad Amin Vahedi, Mohsen Abadi, Alireza Fazeli Bavand-Pour, Fatemeh Sadat Baghestani, Ahmad Reza Leukemia Cancer Mortality Trend in Iran, From 1995 to 2004 |
title | Leukemia Cancer Mortality Trend in Iran, From 1995 to 2004 |
title_full | Leukemia Cancer Mortality Trend in Iran, From 1995 to 2004 |
title_fullStr | Leukemia Cancer Mortality Trend in Iran, From 1995 to 2004 |
title_full_unstemmed | Leukemia Cancer Mortality Trend in Iran, From 1995 to 2004 |
title_short | Leukemia Cancer Mortality Trend in Iran, From 1995 to 2004 |
title_sort | leukemia cancer mortality trend in iran, from 1995 to 2004 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142927/ https://www.ncbi.nlm.nih.gov/pubmed/25250129 |
work_keys_str_mv | AT fazelizeinab leukemiacancermortalitytrendiniranfrom1995to2004 AT pourhoseingholimohamadamin leukemiacancermortalitytrendiniranfrom1995to2004 AT vahedimohsen leukemiacancermortalitytrendiniranfrom1995to2004 AT abadialireza leukemiacancermortalitytrendiniranfrom1995to2004 AT fazelibavandpourfatemehsadat leukemiacancermortalitytrendiniranfrom1995to2004 AT baghestaniahmadreza leukemiacancermortalitytrendiniranfrom1995to2004 |